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This glossary contains the new terms listed at the beginning of Modules 6–9.
active case finding— identifying unreported cases of TB disease by actively 
searching for them through, for example, laboratory and pharmacy audits
adherence agreement— a written document that describes understanding between 
a health care worker and a patient regarding TB treatment adherence and completion
adherence plan— a written plan that is based on the patient’s understanding and 
acceptance of the TB diagnosis and recommended treatment. It addresses barriers 
to adherence and details the method chosen to deliver treatment and monitor 
adherence for that specific patient. 
adherence to treatment— following the recommended course of treatment by 
taking all of the prescribed medications for the entire recommended time
authorization— permission given by the patient to allow a third party to have access 
to the patient’s confidential information
autonomy— the right of a patient to determine what will be done with his or her 
body, personal belongings, and personal information; this concept applies to any 
adult person who is mentally competent
barriers— anything that may prevent a patient from being able to adhere to a TB 
treatment regimen
case— a person with suspected or confirmed TB disease; sometimes referred to as 
an index case or index patient
case conference— meetings at designated intervals for reviewing the treatment 
of TB patients currently under care. During a case conference, the case manager 
presents information to colleagues about the status of each case under medical care 
and the progress of the contact investigation.
case management— a strategy health departments can use to manage patient care 
and help ensure patients successfully complete treatment
case manager— a specific health care worker who is assigned primary responsibility 
for the patient
case review— the systematic, regular review of a patient’s progress by the case 
management team. Case reviews should be weekly and real-time. 
1
Glossary— Self-Study Modules on Tuberculosis, 6–9 
chain of transmission— often used to describe the circumstances and timing of 
transmission from a source case to one or more persons who develop TB disease 
(secondary cases). A chain of transmission can extend over a few months, years, 
or decades. Cases involved in the same chain of transmission almost always have 
matching genotypes (when this information is available).
clinic-based directly observed therapy (DOT)— DOT that is delivered in a TB 
clinic or comparable healthcare facility
cohort review— the systematic review of the management of a specific cohort of 
TB patients and their contacts. A “cohort” is a group of TB cases counted over a 
specific period of time, usually 3 months.
confidentiality— the protection of all patient information, including patient 
records and information discussed or identified during patient-health care worker 
encounters
congregate setting— a setting in which a group of persons reside, meet, or gather 
either for a limited or extended period of time in close physical proximity. Examples 
include prisons, nursing homes, schools, and homeless shelters.
contacts— persons exposed to someone with infectious TB disease, can include 
family members, roommates or housemates, close friends, coworkers, classmates, 
and others 
contact investigation— a systematic process to identify persons (contacts) who 
were exposed to someone with infectious TB disease; assess contacts for infection 
with M. tuberculosis and TB disease; and provide contacts with treatment for latent 
TB infection or TB disease, if necessary
court order— an order issued by a court mandating an action such as compliance 
with directly observed therapy (DOT) or, in very rare cases, detention in a facility 
until treatment is completed
court-ordered directly observed therapy (DOT)— DOT that is administered to a 
patient by order of a public health official or a court with the appropriate authority
cultural competence— having the capacity to function effectively as an individual 
and an organization within the context of the cultural beliefs, behaviors, and needs 
presented by patients and their communities
data security— protection of public health data and information systems to prevent 
unauthorized release of identifying information and accidental loss of data or 
damage to the systems. Security measures include measures to detect, document, 
and counter threats to data confidentiality or the integrity of data systems.
degree of infectiousness— physical or environmental characteristics that can affect 
ability to transmit M. tuberculosis
descriptive epidemiology— the aspect of epidemiology concerned with organizing 
and summarizing health-related data according to person, place, and time
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discharge planning— the preparation for continued and comprehensive care of a 
patient after that patient’s discharge from a hospital or institution
disclosure— the act of revealing or distributing personal information
enablers— things that make it possible or easier for patients to receive treatment 
by overcoming barriers
epidemic curve (epi curve)— a graph that displays the number of TB cases and 
when they were identified. Time is plotted on the horizontal x-axis and the number 
of cases is plotted on the vertical y-axis. 
epidemiologic link (epi link)— characteristic(s) TB patients share that explains 
where and when TB could have been transmitted between them 
exposure period— the timeframe during which a contact may have been infected 
with M. tuberculosis 
field visit— visiting a TB case’s residence, congregate settings, and other places 
where the TB case spent time while infectious. A field visit can also be used to 
locate or meet contacts.
field-based directly observed therapy (DOT)— DOT that is delivered in a setting 
outside of the TB clinic or healthcare facility
genotype— distinct genetic pattern of an organism
genotype cluster— when two or more cases have matching genotypes
genotyping— a laboratory-based method that can determine the genetic pattern of 
the strain of M. tuberculosis that caused TB disease in a person
Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule—  
provides national standards for protecting the privacy of health information. The 
Privacy Rule regulates how organization’s and health care workers use and disclose 
certain individually identifiable health information.
incentives— small rewards given to patients to encourage them to either take their 
medicine or keep their clinic or field DOT appointments
index case— the initial TB case that prompts a contact investigation
infectious— refers to a disease that is capable of being spread; a person who has 
infectious TB disease expels droplets containing M. tuberculosis into the air when 
he or she coughs, sneezes, speaks, or sings
infectious period— time during which a TB case is potentially capable of 
transmitting M. tuberculosis
location-based investigation— an approach for conducting contact investigations 
onsite at a location where the TB case spent time while infectious. The purpose is 
to identify and assess potential TB contacts at that location.
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nonadherence— a patient’s inability or refusal to take TB drugs as prescribed
open-ended questions— a question that cannot be answered with a simple “yes” or 
“no.” Open-ended questions are designed to elicit the patient’s knowledge, feelings, 
and beliefs.
outbreak case definition— a standard set of criteria for deciding which TB cases 
could be involved in an outbreak
outbreak hypotheses— theories about how, when, and where TB transmission 
may have occurred during an outbreak
outbreak line list— summary of the cases that meet the outbreak case definition
passive case reporting— required reporting of suspected or confirmed TB cases 
to a public health authority
patient assessment— talking to a patient about his or her medical history, 
knowledge about TB, and beliefs about TB treatment
patient-identifiable information— information in which the identity of the patient 
is directly included or can be deduced
pre-interview phase— reviewing existing information about the TB case before 
the first interview; typically this is the first step in the systematic approach to 
contact investigation
prevalence of TB infection— the percentage of persons infected with  
M. tuberculosis within a defined population
priority contacts— contacts who are at most risk for TB infection or disease
privileged information— personal information shared by the patient with a health 
care worker
protected health information (PHI)— individually identifiable health information 
that is transmitted or maintained in a database; this can be electronic media or 
any other form or medium. The protected information must relate to 1) the past, 
present, or future physical or mental health condition of an individual; 2) provision 
of health care to an individual; or 3) payment for the provision of health care to 
an individual. If the information identifies or provides a reasonable basis to believe 
it can be used to identify an individual, it is considered individually identifiable 
health information.
proxy— a person interviewed in place of a TB case. Potential proxies include 
family members, close friends, or other persons who know the person well. 
A proxy is used if the TB case is deceased, physically or mentally unable to 
participate in interviews, very young, or unable to be located.
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proxy interview— an interview with persons (proxies) who are familiar with the 
TB case’s practices, habits, and behaviors
quality assurance— the review and evaluation of the quality of care and 
effectiveness of the TB program
recent transmission— transmission of TB that has occurred in the recent past,  
as opposed to reactivation of latent TB infection. Although the precise time 
period is not well defined, “recent” transmission is often considered to be within 
the last 2 years.
secondary case— an instance of TB after a known exposure, usually related to 
the index case in an investigation
secondary transmission— when any of the secondary case’s contacts are found 
to have latent TB infection or TB disease
security— protection of public health data and information systems to prevent 
unauthorized release of identifying information and accidental loss of data or 
damage to the systems. Security measures include measures to detect, document, 
and counter threats to data confidentiality or the integrity of data systems.
source case— a person with TB disease who is responsible for transmitting  
M. tuberculosis to another person or persons 
source case investigation— a method used to identify a source case; usually 
done when a young child is found to have TB disease 
spot map— a technique for showing where cases may have been exposed to TB 
or where they may have exposed others after developing TB disease
statement of disagreement— a statement filed by the patient stating there  
is a disagreement with the health care worker or institution regarding the  
patient’s record
TB case surveillance— monitoring the occurrence of TB disease in specific 
geographic areas, populations, and time periods
TB genotyping information management system (TB GIMS)— a secure  
CDC-sponsored online national database of M. tuberculosis genotyping and  
TB case information
TB health care worker— any person who cares for and manages TB patients, 
including physicians, nurses, case managers, outreach workers, hospital discharge 
planners, pharmacists, social workers, peer educators, and volunteers
TB outbreak— when there are more TB cases than expected within a geographic 
area or population during a particular time period, and there is evidence of recent 
transmission of M. tuberculosis among those cases
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TB outbreak response— a process used by public health programs to investigate 
and intervene when a TB outbreak is suspected or confirmed
TB outbreak response plan— an action plan that helps guide outbreak response
third party— a person or an organization not directly involved in the patient’s care
tumor necrosis factor-alpha (TNF-alpha) antagonists, inhibitors, or blockers—  
medications used to treat inflammatory or autoimmune diseases such as rheumatoid 
arthritis, Crohn’s disease, psoriatic arthritis, and juvenile rheumatoid arthritis
waiver— a form that patients are often asked to sign to allow their health 
information to be used by third parties
window period— the time between the contact’s last exposure to the TB case and 
when a tuberculin skin test (TST) or interferon-gamma release assay (IGRA) can 
reliably detect infection with M. tuberculosis
window period prophylaxis— treatment for latent TB infection that is given to 
high-risk contacts who have an initial negative test result for TB infection less than 
8 to 10 weeks after their last TB exposure
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